Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Chief Operating Officer sold 8,816 shares at an average $1.72 ($15,197)
  3. 4 Open-market sale Chief Patient Supply Officer sold 8,816 shares at an average $1.72 ($15,197)
  4. 4 Open-market sale Chief Medical Officer sold 11,292 shares at an average $1.72 ($19,421)
  5. 4 Open-market sale Chief Executive Officer sold 31,805 shares at an average $1.72 ($54,791)
  6. 4 Open-market sale Chief Operating Officer sold 3,584 shares at $1.69 ($6,071)
  7. 4 Open-market sale Chief Patient Supply Officer sold 1,100 shares at $1.69 ($1,863)
  8. 4 Open-market sale Chief Medical Officer sold 876 shares at $1.69 ($1,484)
  9. 4 Open-market sale Chief Executive Officer sold 5,073 shares at $1.69 ($8,594)
  10. 4 Open-market sale Chief Executive Officer sold 2,536 shares at $1.97 ($4,993)
  11. 4 Open-market sale Chief Patient Supply Officer sold 2,983 shares at $1.77 ($5,290)
  12. 4 Open-market sale Chief Commercial Officer sold 21,040 shares at $1.77 ($37,314)
  13. 4 Open-market sale Chief Patient Supply Officer sold 1,973 shares at $1.68 ($3,311)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 18 · 351 filings